Peter Koefoed

Partner Inspicos

+45 4516 6171

Contact

Published by this author:

Sponsored content

Sponsored by Inspicos

Substance, composition, or device? EPO addresses method of reaching a decision

While concrete definitions are still lacking, Peter Koefoed of Inspicos says patent applicants seeking protection for second medical uses of products could now find it easier to build their case

Peter Koefoed, March 14 2024
Sponsored by Inspicos

EPO: Enlarged Board considers patentability of simulations

Peter Koefoed of Inspicos P/S explains the findings of a recent decision concerning the inventiveness of computer-implemented simulation methods

Peter Koefoed, May 13 2021
Sponsored by Inspicos

EPO: Plants which are not patentable

The Enlarged Board of Appeal of the EPO (EBA) has recently issued opinion G 3/19, which concludes that plants and animals exclusively obtained by “essentially biological processes” are exempt from patentability. This finding only affects patents derived from patent applications filed after July 1 2017.

Peter Koefoed, July 09 2020